limiting the use of OTC cough and cold medicines in young children

New evidence verifies the benefit of limiting the use of OTC cough and cold medicines in young children.

The infant versions are no longer marketed...and the remaining children's products are no longer labeled for children under age 4 or 6.

Now a new report suggests this is making a big difference.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote